AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review
- 1 November 2019
- journal article
- review article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 17 (12), 2416-2422
- https://doi.org/10.1016/j.cgh.2019.07.011
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Cancer surveillance in patients with primary sclerosing cholangitisHepatology, 2011
- The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse populationBMC Gastroenterology, 2011
- Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have CholangiocarcinomaClinical Gastroenterology and Hepatology, 2011
- Serum CA 19-9 as a Biomarker for Pancreatic Cancer—A Comprehensive ReviewIndian Journal of Surgical Oncology, 2011
- Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: Unique clinical and human leukocyte antigen associationsLiver Transplantation, 2010
- Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitisHepatology, 2008
- The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing CholangitisDigestive Diseases and Sciences, 2005
- Serum and Bile Markers for CholangiocarcinomaSeminars in Liver Disease, 2004
- Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation.Gut, 1991
- Orthotopic Liver Transplantation for Primary Sclerosing CholangitisAnnals of Surgery, 1988